pI: 10.0962 |
Length (AA): 434 |
MW (Da): 51638 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
73 | 424 | 2qhs (A) | 2 | 210 | 25.00 | 0 | 1 | 0.33896 | 1.34 |
217 | 255 | 1w66 (A) | 70 | 114 | 51.00 | 0.44 | 0.15 | 0.306962 | 1.49 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Ring. | Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 48 hs, Oocyst, Sporozoite. | Otto TD Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, Female Gametocyte, Male Gametocyte. | Otto TD Lasonder E |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_127515)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G31050 | Biotin/lipoate A/B protein ligase family |
Arabidopsis thaliana | AT1G47578 | putative lipoyltransferase-like protein |
Arabidopsis thaliana | AT1G04640 | lipoyltransferase 2 |
Brugia malayi | Bm1_52715 | lipoate-protein ligase B containing protein |
Candida albicans | CaO19.10528 | similar to E. coli LipB protein |
Candida albicans | CaO19.3010 | similar to E. coli LipB protein |
Dictyostelium discoideum | DDB_G0275417 | hypothetical protein |
Drosophila melanogaster | Dmel_CG9804 | CG9804 gene product from transcript CG9804-RA |
Escherichia coli | b0630 | octanoyltransferase |
Echinococcus granulosus | EgrG_000444900 | octanoyltransferase mitochondrial |
Echinococcus multilocularis | EmuJ_000444900 | octanoyltransferase, mitochondrial |
Homo sapiens | ENSG00000175536 | lipoyl(octanoyl) transferase 2 (putative) |
Leishmania braziliensis | LbrM.35.3300 | lipoate protein ligase, putative |
Leishmania donovani | LdBPK_363230.1 | Octanoyltransferase, putative |
Leishmania infantum | LinJ.36.3230 | lipoate protein ligase, putative |
Leishmania major | LmjF.36.3080 | lipoate protein ligase, putative |
Leishmania mexicana | LmxM.36.3080 | lipoate protein ligase, putative |
Loa Loa (eye worm) | LOAG_00038 | hypothetical protein |
Mycobacterium leprae | ML0859c | Probable lipoate biosynthesis protein B LipB |
Mus musculus | 67164 | lipoyl(octanoyl) transferase 2 (putative) |
Mycobacterium tuberculosis | Rv2217 | Probable lipoate biosynthesis protein B LipB |
Mycobacterium ulcerans | MUL_1344 | lipoate-protein ligase B |
Neospora caninum | NCLIV_058320 | Strongly similar to lipoyltransferase, related |
Oryza sativa | 4332681 | Os03g0321800 |
Oryza sativa | 4352692 | Os12g0596000 |
Onchocerca volvulus | OVOC6679 | Putative lipoyltransferase 2, mitochondrial |
Plasmodium berghei | PBANKA_0707000 | lipoate-protein ligase B |
Plasmodium falciparum | PF3D7_0823600 | lipoate-protein ligase B |
Plasmodium knowlesi | PKNH_1317600 | lipoate-protein ligase B, putative |
Plasmodium vivax | PVX_089180 | lipoate-protein ligase B, putative |
Plasmodium yoelii | PY04501 | putative ligase in lipoate biosynthesis |
Saccharomyces cerevisiae | YLR239C | lipoyl(octanoyl) transferase LIP2 |
Schistosoma japonicum | Sjp_0218640 | expressed protein |
Schistosoma japonicum | Sjp_0114740 | ko:K03801 lipoyl(octanoyl) transferase, putative |
Schistosoma mansoni | Smp_176550 | lipoate-protein ligase B |
Schmidtea mediterranea | mk4.005587.00 | Putative lipoyltransferase 2, mitochondrial |
Schmidtea mediterranea | mk4.058520.02 | Putative lipoyltransferase 2, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.11.10520 | lipoate-protein ligase, putative,lipoyltransferase, putative |
Trypanosoma brucei | Tb927.11.9390 | Octanoyltransferase, putative |
Trypanosoma congolense | TcIL3000.11.9800 | Octanoyltransferase, putative |
Trypanosoma cruzi | TcCLB.511587.120 | Octanoyltransferase, putative |
Trypanosoma cruzi | TcCLB.508851.40 | Octanoyltransferase, putative |
Toxoplasma gondii | TGME49_315640 | lipoyl(octanoyl) transferase |
Wolbachia endosymbiont of Brugia malayi | Wbm0235 | lipoate-protein ligase B |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.1160 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.1160 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.1160 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.1160 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0630 | Escherichia coli | non-essential | goodall |
PBANKA_0707000 | Plasmodium berghei | Dispensable | plasmo |
TGME49_315640 | Toxoplasma gondii | Essentiality uncertain | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.